Patents by Inventor Albert Meyer

Albert Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11810303
    Abstract: The present application relates to an automated segmentation method for use with echocardiograms (echo). The method uses an iterative Dijkstra's algorithm, a strategic node selection, and a novel cost matrix formulation based on intensity peak prominence and is this termed the “Prominence Iterative Dijkstra's” algorithm, or ProID.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: November 7, 2023
    Assignee: Purdue Research Foundation
    Inventors: Brett Albert Meyers, Pavlos P. Vlachos, Melissa Brindise
  • Patent number: 11763456
    Abstract: The present application includes a method and a software architecture for measuring global longitudinal strain (GLS) and global longitudinal strain rate (GLSr) from 2D echocardiograms. In contrast to conventional GLS computation methods, this approach does not require boundary segmentation and regularization.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: September 19, 2023
    Assignee: Purdue Research Foundation
    Inventors: Brett Albert Meyers, Pavlos P. Vlachos
  • Patent number: 11390643
    Abstract: The present invention relates to a modified oligonucleotide having two or more thiol functions, which can be immobilized on a gold surface or on a grafted surface, in particular a surface comprising at least one carbon-carbon double bond or carbon-carbon triple bond or haloacetamide functions, preferably maleimide or acrylamide functions. The invention also relates to a method for detecting a nucleic acid in a biological sample comprising a step of detecting hybridization between a modified oligonucleotide and a target nucleic acid amplified from the biological sample. The invention relates more particularly to a method for detecting, genotyping or sequencing a pathogenic organism, preferably a virus.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: July 19, 2022
    Assignees: ETABLISSEMENT FRANÇAIS DU SANG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE MONTPELLIER, UNIVERSITE CLAUDE BERNARD LYON 1
    Inventors: Chantal Fournier-Wirth, Myriam Lereau, Jean-François Cantaloube, Jean-Jacques Vasseur, François Morvan, Albert Meyer, Julie Mayen, Carole Chaix, Carole Farre
  • Publication number: 20210287371
    Abstract: The present application includes a method and a software architecture for measuring global longitudinal strain (GLS) and global longitudinal strain rate (GLSr) from 2D echocardiograms. In contrast to conventional GLS computation methods, this approach does not require boundary segmentation and regularization.
    Type: Application
    Filed: March 11, 2021
    Publication date: September 16, 2021
    Applicant: Purdue Research Foundation
    Inventors: Brett Albert Meyers, Pavlos P. Vlachos
  • Publication number: 20210287375
    Abstract: The present application relates to an automated segmentation method for use with echocardiograms (echo). The method uses an iterative Dijkstra's algorithm, a strategic node selection, and a novel cost matrix formulation based on intensity peak prominence and is this termed the “Prominence Iterative Dijkstra's” algorithm, or ProID.
    Type: Application
    Filed: March 11, 2021
    Publication date: September 16, 2021
    Applicant: Purdue Research Foundation
    Inventors: Brett Albert Meyers, Pavlos P. Vlachos, Melissa Brindise
  • Patent number: 11078229
    Abstract: The present invention relates to a thiol compound suitable for forming a chain of oligomers that can be grafted to an oligonucleotide. The invention also relates to an oligonucleotide grafted by such a compound, thus having one or more thiol functions, suitable for being immobilized on a gold surface or on a grafted surface.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: August 3, 2021
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ETABLISSEMENT FRANCAIS DU SANG
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Julie Mayen, Carole Chaix, Carole Farre, Chantal Fournier-Wirth, Jean-François Cantaloube, Myriam Lereau
  • Publication number: 20190376151
    Abstract: The present invention relates to a modified oligonucleotide having two or more thiol functions, which can be immobilized on a gold surface or on a grafted surface, in particular a surface comprising at least one carbon-carbon double bond or carbon-carbon triple bond or haloacetamide functions, preferably maleimide or acrylamide functions. The invention also relates to a method for detecting a nucleic acid in a biological sample comprising a step of detecting hybridization between a modified oligonucleotide and a target nucleic acid amplified from the biological sample. The invention relates more particularly to a method for detecting, genotyping or sequencing a pathogenic organism, preferably a virus.
    Type: Application
    Filed: February 8, 2019
    Publication date: December 12, 2019
    Inventors: Chantal Fournier-Wirth, Myriam Lereau, Jean-François Cantaloube, Jean-Jacques Vasseur, François Morvan, Albert Meyer, Julie Mayen, Carole Chaix, Carole Farre
  • Publication number: 20180265538
    Abstract: The present invention relates to a thiol compound suitable for forming a chain of oligomers that can be grafted to an oligonucleotide. The invention also relates to an oligonucleotide grafted by such a compound, thus having one or more thiol functions, suitable for being immobilized on a gold surface or on a grafted surface.
    Type: Application
    Filed: January 4, 2018
    Publication date: September 20, 2018
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Julie Mayen, Carole Chaix, Carole Farre, Chantal Fournier-Wirth, Jean-François Cantaloube, Myriam Lereau
  • Patent number: 9896473
    Abstract: The present invention relates to a thiol compound suitable for forming a chain of oligomers that can be grafted to an oligonucleotide. The invention also relates to an oligonucleotide grafted by such a compound, thus having one or more thiol functions, suitable for being immobilized on a gold surface or on a grafted surface.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: February 20, 2018
    Assignees: Etablissement Francais du Sang, Centre National de la Recherche Scientifique (CNRS)
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Julie Mayen, Carole Chaix, Carole Farre, Chantal Fournier-Wirth, Jean-François Cantaloube, Myriam Lereau
  • Publication number: 20150232957
    Abstract: The present invention relates to a modified oligonucleotide having two or more thiol functions, which can be immobilized on a gold surface or on a grafted surface, in particular a surface comprising at least one carbon-carbon double bond or carbon-carbon triple bond or haloacetamide functions, preferably maleimide or acrylamide functions. The invention also relates to a method for detecting a nucleic acid in a biological sample comprising a step of detecting hybridization between a modified oligonucleotide and a target nucleic acid amplified from the biological sample. The invention relates more particularly to a method for detecting, genotyping or sequencing a pathogenic organism, preferably a virus.
    Type: Application
    Filed: April 4, 2013
    Publication date: August 20, 2015
    Inventors: Chantal Fournier-Wirth, Myriam Lereau, Jean-François Cantaloube, Jean-Jacques Vasseur, François Morvan, Albert Meyer, Julie Mayen, Carole Chaix, Carole Farre
  • Publication number: 20150158964
    Abstract: The present invention relates to a thiol compound suitable for forming a chain of oligomers that can be grafted to an oligonucleotide. The invention also relates to an oligonucleotide grafted by such a compound, thus having one or more thiol functions, suitable for being immobilized on a gold surface or on a grafted surface.
    Type: Application
    Filed: April 4, 2013
    Publication date: June 11, 2015
    Applicant: UNIVERSITE CLAUDE BERNARD LYON 1
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Julie Mayen, Carole Chaix, Carole Farre, Chantal Fournier-Wirth, Jean-François Cantaloube, Myriam Lereau
  • Patent number: 8304532
    Abstract: A solution phase synthesis method for preparing an oligonucleotide, wherein at least some of the reagents are solid supported. The method suitable for large-scale synthesis comprises coupling a protected compound with a nucleotide derivative having a protection group in the presence of a solid supported activator to give an elongated oligonucleotide with a P(III)-internucleotide bond; optionally processing the elongated oligonucleotide by capping by reaction with a solid supported capping agent and/or by oxidizing or sulfurizing by reaction of the oligonucleotide with a solid supported oxidizing or sulfurization reagent; and removing the protection group. The coupling may include reacting a 3?-protected compound of formula: with a nucleotide derivative having a 5?-protection group, or reacting a 5?-protected compound of formula with a nucleotide derivative having a 3?-protection group.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: November 6, 2012
    Assignees: Girindus AG, Centre National de la Recherche Scientifique, University of Montpellier II
    Inventors: Ilaria Adamo, Cecile Dueymes, Andreas Schonberger, Jean-Louis Imbach, Albert Meyer, Francois Morvan, Francoise Debart, Jean-Jacques Vasseur, Meinolf Lange, Fritz Link
  • Patent number: 8183355
    Abstract: Method for the synthesis of nucleotide derivatives wherein molecules of interest are grafted on the oligonucleotide with the help of a “click chemistry” reaction between an azide function on the molecule of interest and an alkyne function on the oligonucleotide, or between an alkyne function on the molecule of interest and an azide function on the oligonucleotide. Intermediate molecules, notably alkyne functionalized oligonucleotides, grafted oligonucleotides, azide functionalized oligonucleotides, oligonucleotide micro arrays containing them and the use of those grafted oligonucleotides for biological investigation and for cell targeting.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: May 22, 2012
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Sébastien Vidal, Jean-Pierre Cloarec, Yann Chevolot, Eliane Souteyrand
  • Publication number: 20110245478
    Abstract: Method for the synthesis of nucleotide derivatives wherein molecules of interest are grafted on the oligonucleotide with the help of a “click chemistry” reaction between an azide function on the molecule of interest and an alkyne function on the oligonucleotide, or between an alkyne function on the molecule of interest and an azide function on the oligonucleotide. Intermediate molecules, notably alkyne functionalized oligonucleotides, grafted oligonucleotides, azide functionalized oligonucleotides, oligonucleotide micro arrays containing them and the use of those grafted oligonucleotides for biological investigation and for cell targeting.
    Type: Application
    Filed: April 7, 2011
    Publication date: October 6, 2011
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Sébastien Vidal, Jean-Pierre Cloarec, Yann Chevolot, Eliane Souteyrand
  • Publication number: 20110224424
    Abstract: A solution phase synthesis method for preparing an oligonucleotide, wherein at least some of the reagents are solid supported. The method suitable for large- scale synthesis comprises coupling a protected compound with a nucleotide derivative having a protection group in the presence of a solid supported activator to give an elongated oligonucleotide with a P(III)-internucleotide bond; optionally processing the elongated oligonucleotide by capping by reaction with a solid supported capping agent and/or by oxidizing or sulfurizing by reaction of the oligonucleotide with a solid supported oxidizing or sulfurization reagent; and removing the protection group. The coupling may include reacting a 3?-protected compound of formula: with a nucleotide derivative having a 5?-protection group, or reacting a 5?-protected compound of formula with a nucleotide derivative having a 3?-protection group.
    Type: Application
    Filed: May 25, 2011
    Publication date: September 15, 2011
    Applicants: GIRINDUS AG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITY OF MONTPELLIER II
    Inventors: Ilaria ADAMO, Cécile DUEYMES, Andreas SCHÖNBERGER, Jean-Louis IMBACH, Albert MEYER, Francois MORVAN, Francoise DEBART, Jean-Jacques VASSEUR, Meinolf LANGE, Fritz LINK
  • Patent number: 7988381
    Abstract: A vehicle disabling apparatus may include at least one plunger assembly having a plunger and a toggle operable to pivot inside the vehicle tire. The apparatus may include energetic material disposed adjacent the plunger and configured to force the plunger into a vehicle tire. A method of disabling a vehicle having a tire may include using the vehicle's tire to move the plunger and thereby activate the energetic material; and moving the plunger into the tire using gas produced by the energetic material.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: August 2, 2011
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Albert Meyer-Pflug, Victor N. Kokodis, Frank Dindl, Warren G. Reiner, Jr., Michael Heayn
  • Patent number: 7951926
    Abstract: Method for the synthesis of nucleotide derivatives wherein molecules of interest are grafted on the oligonucleotide with the help of a “click chemistry” reaction between an azide function on the molecule of interest and an alkyne function on the oligonucleotide, or between an alkyne function on the molecule of interest and an azide function on the oligonucleotide. Intermediate molecules, notably alkyne functionalized oligonucleotides, grafted oligonucleotides, azide functionalized oligonucleotides, oligonucleotide micro arrays containing them and the use of those grafted oligonucleotides for biological investigation and for cell targeting.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: May 31, 2011
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: François Morvan, Albert Meyer, Jean-Jacques Vasseur, Sébastien Vidal, Jean-Pierre Cloarec, Yann Chevolot, Eliane Souteyrand
  • Publication number: 20100069623
    Abstract: A solution phase synthesis method for preparing an oligonucleotide, wherein at least some of the reagents are solid supported. The method suitable for large-scale synthesis comprises coupling a protected compound with a nucleotide derivative having a protection group in the presence of a solid supported activator to give an elongated oligonucleotide with a P(III)-internucleotide bond; optionally processing the elongated oligonucleotide by capping by reaction with a solid supported capping agent and/or by oxidizing or sulfurizing by reaction of the oligonucleotide with a solid supported oxidizing or sulfurization reagent; and removing the protection group. The coupling may include reacting a 3?-protected compound of formula: with a nucleotide derivative having a 5?-protection group, or reacting a 5?-protected compound of formula with a nucleotide derivative having a 3?-protection group.
    Type: Application
    Filed: April 3, 2009
    Publication date: March 18, 2010
    Applicants: GIRINDUS AG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITY OF MONTPELLIER II
    Inventors: Ilaria Adamo, Cècile Dueymes, Andreas Schönberger, Jean-Louis Imbach, Albert Meyer, Francois Morvan, Francoise Debart, Jean-Jacques Vasseur, Meinolf Lange, Fritz Link
  • Publication number: 20090124571
    Abstract: Method for the synthesis of nucleotide derivatives wherein molecules of interest are grafted on the oligonucleotide with the help of a “click chemistry” reaction between an azide function on the molecule of interest and an alkyne function on the oligonucleotide, or between an alkyne function on the molecule of interest and an azide function on the oligonucleotide. Intermediate molecules, notably alkyne functionalized oligonucleotides, grafted oligonucleotides, azide functionalized oligonucleotides, oligonucleotide micro arrays containing them and the use of those grafted oligonucleotides for biological investigation and for cell targeting.
    Type: Application
    Filed: April 26, 2007
    Publication date: May 14, 2009
    Inventors: Francois Morvan, Albert Meyer, Jean-Jacques Vasseur, Sebastien Vidal, Jean-Pierre Cloarec, Yann Chevolot, Eliane Souteyrand
  • Publication number: 20060089494
    Abstract: A method for preparing an oligonucleotide comprising the steps of a) providing a 3-protected compound having the formula: wherein B is a heterocyclic base R2 is H, a protected 2-hydroxyl group, F, a protected amino group, an O-alkyl group, an O-substituted alkyl, a substituted alkylamino or a C4?-O2?methylen linkage R3 is OR?3, NHR?3, NR?3R??3, a 3?-protected nucleotide or a 3?-protected oligonucleotide, R?3 is a hydroxyl protecting group, R?3, R??3 are independently an amine protecting group, b) reacting said compound with a nucleotide derivative having a 5-proctection group in the presence of a solid supported activator to give an elongated oligonucleotide with a P(III)-internucleotide bond c) optionally processing the elongated oligonucleotide with a P(III)-internucleotide bond by either or both of steps c1) and c2) in any sequence c1) capping preferably by reacting with a solid supported capping agent c2) oxidizing preferably by reacting the oligonucleotide with a solid supported oxidizing reagent d) remo
    Type: Application
    Filed: July 30, 2003
    Publication date: April 27, 2006
    Applicants: Girindus AG, Centre National De La Recherche Scientifique, University of Montpellier II
    Inventors: Ilaria Adamo, Cecile Dueymes, Andreas Schonberger, Jean-Louis Imbach, Albert Meyer, Francois Morvan, Francoise Debart, Jean-Jacques Vasseur, Meinolf Lange, Fritz Link